Read about our @cclguk.bsky.social @littleprincesses.bsky.social funded research published in @bloodjournals.hematology.org . Well done Joe Cross and Lucy Field. Many thanks to Tom Milne and other collaborators. @oxfordpaediatrics.bsky.social @imm.ox.ac.uk ashpublications.org/bloodadvance...

Join me in The Science of Childhood Cancer lecture series hosted by @StJudeResearch this Thursday, September 25 at 12 CT/1pm ET where I will be presenting Developmental origins of infant acute lymphoblastic leukaemia. Register to attend: ow.ly/yzf550T7Iv3

Had a wonderful time as always at CLRUK annual meeting. It was great fun organising it with Lisa Russell, Karen Keeshan and Bill Grey . Very proud of Lucy Hamer for an excellent talk! #CCAM #bloodcancerawarenessmonth

Well done to @emilysn1.bsky.social from our group @imm.ox.ac.uk @oxfordpaediatrics.bsky.social for this award from the Kaiya Foundation to study VHR childhood ALL. #CCAM #bloodcancerawareness month. x.com/ttvoxfordshi...

See you all in York tomorrow for our annual CLRUK meeting. We have some exciting talks from students and ECRs and a keynote from Prof @adelekfielding.bsky.social

Please share: we’re recruiting a postdoctoral fellow – applications open until September 15! To lead genomics data analysis of an exciting translational project in sAML cancer, supportive environment, and access to unique in-house technologies. my.corehr.com/pls/uoxrecru...

NEW: Scientists at Oxford University, together with colleagues at @imperialcollegeldn.bsky.social and @uofglasgow.bsky.social, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia. Read more ⬇️

Thanks for highlighting our research!

Very excited about this paper! This was a wonderful collaborative project with Karadimitris lab ⁦ @imperialcollegeldn.bsky.social . Thanks to funders ⁦ @cancerresearchuk.org and ⁦@Children With Cancer UK. On #CCAM , we hope this brings us closer to curing #InfantALL.

NEW: Scientists in the @roylab-oxford.bsky.social have co-led the development of a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia 🧪 #ChildhoodCancerAwarenessMonth @oxfordpaediatrics.bsky.social | @medsci.ox.ac.uk Learn more 👇

Very grateful for this funding from The Kaiya Foundation to study a rare and aggressive form of childhood ALL. Well done to @emilysn1.bsky.social for this award. #CCAM

Congratulations to Emily Neil (@emilysn1.bsky.social) & Andi Roy (@roylab-oxford.bsky.social) on receiving one of The Kaiya Foundation's first major research grants. Learn more 👇

We are hiring! Great opportunity for a RA with bioinformatic skills We are looking for talented researcher to work on a project to detect gene fusions and driver mutations in a large cohort of children with ALL treated across multiple different trials to determine their clinical relevance.

#SAIL Team lunch and meeting in Oxford. An afternoon well spent and some exciting discussions! #infantALL

WIMM day 2025- talks, posters, discussing science and lab dinner! A good day!

Dear CLRUK community! The 2025 Annual meeting will be held in York on 11th Sep. We encourage students and postdocs to present their work and ECRs to volunteer as session chairs. Hope to see you all in beautiful York. Register here 👇

It’s been a busy time in the lab, with lots of student/postdoc presentations! #ProudPI

Are you a parent whose child is undergoing/has previously had treatment for cancer? We welcome you to join our infant leukaemia study team (cancer.ox.ac.uk/research/SAIL) to help develop a parent reported outcome questionnaire. Details of how to join/contact us below. Please share.

Always a pleasure to attend EHA Annual meeting. Well done to WIMM students presenting their work. And a good catch up with all! #EHA2025 @imm.ox.ac.uk

Are you a parent whose child is undergoing/has previously had treatment for cancer? We welcome you to join our infant leukaemia study team (cancer.ox.ac.uk/research/SAIL) to help develop a parent reported outcome questionnaire. Details of how to join/contact us below. Please share.

Well done @ananyam.bsky.social for presenting your research at the @oxfordpaediatrics.bsky.social Student Research Day!

It was wonderful to have Ana in our lab for a few months. Farewell dinner before her return to Uni of Salamanca

Happy International Women’s Day to all the great women in science I have been fortunate to know and work with!

On rare diseases day, I am really happy to say that our website for the SAIL study is now live. We are collecting clinical and research data and parent reported outcomes for this rare disease in the U.K. Thanks to @cancerresearchuk.org and GOSH Charity for the funding.

To conclude our #RareDiseaseDay series, we spoke with @ellouka.bsky.social, a clinician scientist researching Paediatric Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leukaemia (JMML). These are incredibly rare childhood cancers, with no current treatment options available. 🧪

Good morning everyone, I'm pleased to share our latest advance in bone marrow in vitro modelling: www.biorxiv.org/content/10.1...

What a wonderful @emboevents.bsky.social workshop we had in Kolkata. Science, networking and brilliant presentations from researchers at every stage of career. It was an absolute honour to participate!

Woohoo! Poster prize for @ananyam.bsky.social . Well done! 👏 👏🎉 @cclguk.bsky.social @imm.ox.ac.uk @oxfordpaediatrics.bsky.social @Azaylia Foundation

Very proud of Ananya Mahadevan who presented data from her DPhil project funded by @cclguk.bsky.social and Azaylia Foundation

Day 1 of @emboevents.bsky.social workshop in Kolkata. A packed day with some great talks and wonderful discussions!

Cancer is one of the MRC WIMM's five core research areas. 🧪 For #WorldCancerDay last year, we spoke to some of our group leaders about their work and how their groups are helping in the fight against cancer, including @roylab-oxford.bsky.social & @bpfairfax.bsky.social. Watch the video:

This is more urgent than we realise. We are losing talented clinician researchers in the U.K. because of several funding bottlenecks and an inflexible training>>CCT system.

Well done Rebecca, for presenting your DPhil project at OCH Day @imm.ox.ac.uk . @oxfordcancer.bsky.social @oxfordpaediatrics.bsky.social

Preprint alert: this was a wonderful collaborative project with Prof Karadimitris @imperialcollegeldn.bsky.social and many others. Thanks to all and especially @cancerresearchuk.org for the CAYP innovation award funding. All feedback welcome!

Go Lucy! Good luck for the match tonight 🏉 www.instagram.com/reel/DFH2p_M...

Last week we had a belated Christmas + New Year lab party. Must still have Christmas crackers 🤣. Here’s to a wonderful 2025!

The abstract submission deadline has been extended to 10th Jan, to account for the holiday season. Please spread the word.

Last few days to submit an abstract for this meeting! #ChildhoodLeukaemia #EMBO

Last lab meeting of the year! It’s been a good year with this wonderful team! Have a restful holiday season everyone- here’s wishing you all a great 2025 from our lab! 🧫🧬

Registration and abstract submission is now open for this EMBO Childhood Leukaemia workshop that I am excited to help organise. See you in Kolkata!!

Well ASH is always good fun. Some excellent presentations by many @imm.ox.ac.uk researchers! Special congratulations to the ECRs

Preprint alert: If you missed Rebecca Ling's talk at #ASH24 about the role of LIN28B in lymphopoiesis and infant ALL, please read about it online. All feedback welcome! @oxfordpaediatrics.bsky.social @imm.ox.ac.uk www.biorxiv.org/content/10.1...

Three talks in lymphoid oncogenesis session at #ASH24 from these brilliant ECRs studying infant ALL. 👏👏

Well done Rebecca Ling, for a great talk about her PhD work at #ASH24. #ProudPI

First time by train to #ASH24. On the Pacific Surfliner from LA! @ash-hematology.bsky.social

Great meeting with colleagues to discuss progress of ReCORD study. And some great food too at LA! Thanks @adamdesmith.bsky.social for hosting!

Ready for #ASH24 ? V proud of Rebecca Ling, presenting her PhD work on fetal programmes in infant leukaemia. #ASHKudos for an abstract achievement award! Thanks to all collaborators!